Theranostics 2015; 5(8):890-904. doi:10.7150/thno.11821

Research Paper

Site-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors

Yaqiong Dong1,2,*, Jun Yang1,*, Hongmei Liu1,3, Tianyou Wang4, Suoqin Tang5, Jinchao Zhang2, ✉, Xin Zhang1,✉

1. National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China
2. College of Chemistry & Environmental Science, Chemical Biology Key Laboratory of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Hebei University, Baoding, 071002, China
3. University of Chinese Academy of Sciences, Beijing, 100049, China
4. Capital Institute of Pediatrics, Beijing, 100020, China
5. Department of Pediatrics, The General Hospital of People's Liberation Army, Beijing, 100853, China
* These authors contributed equally to this work.

Abstract

To enhance effective drug accumulation in drug-resistant tumors, a site-specific drug-releasing polypeptide system (PEG-Phis/Pasp-DOX/CA4) was exploited in response to tumor extracellular and intracellular pH. This system could firstly release the embedded tumor vascular inhibitor (CA4) to transiently 'normalize' vasculature and facilitate drug internalization to tumors efficiently, and then initiate the secondary pH-response to set the conjugated active anticancer drug (DOX) free in tumor cells. The encapsulated system (PEG-Phis/DOX/CA4), both CA4 and DOX embedding in the nanoparticles, was used as a control. Comparing with PEG-Phis/DOX/CA4, PEG-Phis/Pasp-DOX/CA4 exhibited enhanced cytotoxicity against DOX-sensitive and DOX-resistant cells (MCF-7 and MCF-7/ADR). Moreover, PEG-Phis/Pasp-DOX/CA4 resulted in enhanced therapeutic efficacy in drug-resistant tumors with reduced toxicity. These results suggested that this site-specific drug-releasing system could be exploited as a promising treatment for cancers with repeated administration.

Keywords: polypeptide nanocarriers, site-specific releasing, combination cancer therapy, dual-pH response, drug resistance.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Dong Y, Yang J, Liu H, Wang T, Tang S, Zhang J, Zhang X. Site-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors. Theranostics 2015; 5(8):890-904. doi:10.7150/thno.11821. Available from http://www.thno.org/v05p0890.htm